Patents Assigned to Life Technologies AS
-
Patent number: 11649479Abstract: Provided herein are compositions, methods and uses that relate to an easy, accurate and reliable dual or duplex assay that determines both protein and nucleic acid amounts in a viral preparation in a single container and further determines full versus empty virion content.Type: GrantFiled: March 22, 2019Date of Patent: May 16, 2023Assignee: LIFE TECHNOLOGIES CORPORATIONInventors: Yixin Li, Bharti Solanki, Sheung-Mei Shih, Peter Bell, Darick Dayne
-
Publication number: 20230146233Abstract: The present disclosure relates to a class of polycyclic compound inhibiting RNA helicase DHX33 and the application thereof. In particular, the present disclosure relates to a compound as represented by formula VII or a pharmaceutically acceptable form thereof, a pharmaceutical composition comprising the same, a preparation method thereof, and a medical use thereof for preventing and/or treating DHX33-related diseases.Type: ApplicationFiled: September 1, 2021Publication date: May 11, 2023Applicant: Shenzhen KeYe Life Technologies, Co., LtdInventors: Yandong Zhang, Xianglu Li
-
Publication number: 20230134044Abstract: A thermal cycler system comprises a sample block configured to receive a sample holder configured to receive a plurality of samples; an adaptor configured to surround a periphery of the sample block; and a drip pan configured to surround a periphery of the adaptor. The drip pan comprises one or more ejector mechanisms and one or more openings, the one or more ejector mechanisms configured to respectively extend through the one or more openings into contact with the sample holder in a state of the sample holder received by the sample block and the adaptor surrounding the periphery of the sample block.Type: ApplicationFiled: December 29, 2022Publication date: May 4, 2023Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Zeqi TAN, Wuh Ken LOH, Siew Yin LEE, Kuan Moon (Bernard) BOO
-
Publication number: 20230133734Abstract: A system for nucleic acid sequencing includes a machine-readable memory and a processor configured to execute machine-readable instructions. The instructions, when executed by the processor, cause the system to expose template polynucleotide strands in a plurality of defined spaces of a sensor array to a series of flows of nucleotide species, the series comprising a sequence of random flows; and obtain, for each of the series of flows of nucleotide species, a signal indicative of how many nucleotide incorporations occurred for that particular flow to determine a predicted sequence of nucleotides corresponding to the template polynucleotide strands.Type: ApplicationFiled: January 23, 2023Publication date: May 4, 2023Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Earl HUBBELL, Jonathan SCHULTZ
-
Patent number: 11639240Abstract: A fluid manifold system includes a first manifold having portions of opposing flexible sheets welded together to form a fluid flow path therebetween, a fluid inlet communicating with the fluid flow path. The fluid flow path of the first manifold includes: a primary flow path communicating with the fluid inlet of the first manifold; and a plurality of spaced apart secondary flow paths that branch off of the primary flow path. Each secondary flow path has a first end communicating with the primary flow path and an opposing second end, each secondary flow path having a diameter that is smaller than a diameter of the primary flow path. The fluid manifold system also includes a plurality of tubular connectors with each tubular connector being secured to the first manifold at the second end of a corresponding one of the secondary flow paths.Type: GrantFiled: September 22, 2021Date of Patent: May 2, 2023Assignee: LIFE TECHNOLOGIES CORPORATIONInventors: Michael E. Goodwin, Jeremy K. Larsen, Patrick L. Draper, Brandon M. Knudsen
-
Patent number: 11639908Abstract: A cartridge assembly, and method of using the same, is provided. The assembly includes a sample processing card and a substrate attached thereto. The card has an injection port for receiving a test sample; at least one metering chamber; a mixing material source for introducing mixing material(s) to the metering chamber; fluid communication channels fluidly connecting the injection port and the mixing material source to the metering chamber; and at least one output port for delivering the test sample to a sensor (e.g., GMR sensor). The substrate has associated therewith: the sensor for sensing analytes in the test sample; electrical contact portions for an electrical connection with a reader unit; and a memory chip. The assembly further includes a pneumatic interface with port(s) and corresponding communication channel(s) fluidly connected to card.Type: GrantFiled: July 26, 2019Date of Patent: May 2, 2023Assignee: ZEPTO LIFE TECHNOLOGY, INC.Inventors: Todd Michael Klein, Keping Song, Minggan Li, Chad Brian Rheault, Wei Wang, Gemma Roselle Mendonsa
-
Publication number: 20230127610Abstract: A computer-implemented method for generating a data visualization for operating a digital polymerase chain reaction (dPCR) system comprises, the method comprising receiving fluorescent emission data comprising a plurality of data points corresponding to fluorescence emission from a plurality of reaction sites of a substrate, the fluorescent emission data indicative of presence or absence of amplification product of a dPCR. The method further comprises displaying a data visualization of the plurality of data points in a spatial representation of the substrate such that each data point is displayed at a relative spatial location of its corresponding reaction site of the plurality of reaction sites of the substrate, a first set of data points being displayed with a first indication based on meeting a first quality value threshold and second set of data points being displayed with a second indication, differing from the first indication, based on a second quality value threshold.Type: ApplicationFiled: September 19, 2022Publication date: April 27, 2023Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Nivedita Sumi MAJUMDAR, Harrison LEONG, Theodore E. STRAUB, David HOARD
-
Publication number: 20230125333Abstract: In one embodiment, a device is described. The device includes a material defining a reaction region. The device also includes a plurality of chemically-sensitive field effect transistors have a common floating gate in communication with the reaction region. The device also includes a circuit to obtain respective output signals from the chemically-sensitive field effect transistors indicating an analyte within the reaction region.Type: ApplicationFiled: October 7, 2022Publication date: April 27, 2023Applicant: Life Technologies CorporationInventors: Jonathan M. ROTHBERG, Keith G FIFE, Jordan OWENS, James BUSTILLO
-
Patent number: 11636919Abstract: A method for evaluating variant likelihood includes: providing a plurality of template polynucleotide strands, sequencing primers, and polymerase in a plurality of defined spaces disposed on a sensor array; exposing the plurality of template polynucleotide strands, sequencing primers, and polymerase to a series of flows of nucleotide species according to a predetermined order; obtaining measured values corresponding to an ensemble of sequencing reads for at least some of the template polynucleotide strands in at least one of the defined spaces; and evaluating a likelihood that a variant sequence is present given the measured values corresponding to the ensemble of sequencing reads, the evaluating comprising: determining a measurement confidence value for each read in the ensemble of sequencing reads and modifying at least some model-predicted values using a first bias for forward strands and a second bias for reverse strands.Type: GrantFiled: May 9, 2018Date of Patent: April 25, 2023Assignee: LIFE TECHNOLOGIES CORPORATIONInventors: Earl Hubbell, Sowmi Utiramerur
-
Patent number: 11636922Abstract: A method for nucleic acid sequencing includes receiving observed or measured nucleic acid sequencing data from a sequencing instrument that receives and processes a sample nucleic acid in a termination sequencing-by-synthesis process. The method also includes generating a set of candidate sequences of bases for the observed or measured nucleic acid sequencing data by determining a predicted signal for candidate sequences using a simulation framework. The simulation framework incorporates an estimated carry forward rate (CFR), an estimated incomplete extension rate (IER), an estimated droop rate (DR), an estimated reactivated molecules rate (RMR), and an estimated termination failure rate (TFR), the RMR being greater than or equal to zero and the TFR being lesser than one. The method also includes identifying, from the set of candidate sequences of bases, one candidate sequence leading to optimization of a solver function as corresponding to the sequence for the sample nucleic acid.Type: GrantFiled: August 26, 2019Date of Patent: April 25, 2023Assignee: LIFE TECHNOLOGIES CORPORATIONInventors: Christian Koller, Marcin Sikora, Peter Vander Horn
-
Patent number: 11634679Abstract: Provided herein is a pipette tip for electroporation including an outer surface, a void located within the outer surface, and a conductor located at least partially on or within the outer surface, in electrical communication with at least a portion of the outer surface and the void. Further provided herein is a pipette tip for electroporation including a body, a connector, and an elongated part. The connector is located at the distal end of the body and further includes at least one connecting post, a connecting part in mechanical communication with the connector, and a conductor located at least partially on or within the connector, wherein the conductor surrounds at least a portion of the connecting post. The elongated part also has a void and is located at the distal end of the connector. The void of the body, connector, and elongated part are in fluid communication.Type: GrantFiled: September 11, 2019Date of Patent: April 25, 2023Assignee: LIFE TECHNOLOGIES CORPORATIONInventors: Jun-Keun Chang, Keun-Chang Cho, Chan-Il Chung, Neon-Cheol Jung, Seung Gin Huh
-
Publication number: 20230112730Abstract: Provided are methods and compositions for preparing a library of target nucleic acid sequences that are useful for assessing gene mutations for oncology biomarker profiling of samples. In particular, a target-specific primer panel is provided that allows for selective amplification of oncology biomarker target sequences in a sample. In one aspect, the invention relates to target-specific primers useful for selective amplification of one or more target sequences associated with oncology biomarkers from two or more sample types. In some aspects, amplified target sequences obtained using the disclosed methods, and compositions can be used in various processes including nucleic acid sequencing and used to detect the presence of genetic variants of one or more targeted sequences associated with oncology.Type: ApplicationFiled: August 15, 2022Publication date: April 13, 2023Applicant: Life Technologies CorporationInventors: David Chi, Aren Ewing, Na Li, Zunping Luo, Amir Marcovitz
-
Publication number: 20230106558Abstract: An instrument for processing and/or measuring a biological process comprises a sample processing system and an excitation source exhibiting a spectral function of output power or intensity verses wavelength of output power or intensity. The spectral function has a minima wavelength corresponding to a local minima value of the output power or intensity; a first maxima wavelength corresponding to a first local maxima of output power or intensity, the output power or intensity at the first local maxima being greater than the output power or intensity at any wavelength less than the minima wavelength; a second maxima wavelength corresponding to a second local maxima of output power or intensity, the output power or intensity at the second local maxima being greater than the output at any wavelength greater than the minima wavelength; the minima wavelength is between the first maxima wavelength and the second maxima wavelength.Type: ApplicationFiled: October 7, 2022Publication date: April 6, 2023Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Mingsong CHEN, Mauro AGUANNO, Kuan Moon BOO, Woon Liang Terence SOH, Jacob K. FREUDENTHAL, Jeffrey A. MARKS
-
Publication number: 20230089830Abstract: Disclosed are a pharmaceutical preparation with a tracing function, and a delivery system therefor. The pharmaceutical preparation comprises a first drug and a second drug in a liquid or gaseous state, wherein the first drug and the second drug are each divided into multiple sections, which are arranged in series at intervals in a conduit. One of the first drug and the second drug is a tracer drug that can be developed in a medical imaging device in the human body. The first drug and the second drug are immiscible and satisfy compatibility requirements. The pharmaceutical preparation can comprise an aerobic contrast agent, an aerobic embolic agent and an aerobic perfusion agent. Same can be applied to a variety of contrast techniques by means of a one-step simple operation, saving the dosage of a drug while maintaining a high concentration of the drug.Type: ApplicationFiled: October 24, 2022Publication date: March 23, 2023Applicant: SUZHOU YIBEN LIFE TECHNOLOGY CO., LTDInventor: Yonghua DONG
-
Publication number: 20230088159Abstract: The present invention provides methods and compositions that are useful for assessing gene expression for tumor immune response profile of a sample. In particular, a target-specific primer panel is provided that allows for selective amplification of immune response target sequences in a sample. In one aspect, the invention relates to target-specific primers useful for selective amplification of one or more target sequences associated with immune response. In some aspects, amplified target sequences obtained using the disclosed methods, and compositions can be used in various processes including nucleic acid sequencing and used to detect the presence of genetic variants and/or expression levels of one or more targeted sequences associated with immune response.Type: ApplicationFiled: July 29, 2022Publication date: March 23, 2023Applicant: Life Technologies CorporationInventors: Ann Mongan, Alex Atkins
-
Patent number: 11607141Abstract: An optical fiber blood pressure continuous detection wristband, comprising: an optical fiber sensing assembly module, the optical fiber sensing assembly module includes a sensing band and an optical fiber configured to extend along the sensing band and form a sensing area to sense a pulse wave; the sensing band includes an inner layer configured to be placed adjacent to the wrist to be detected, and the outer surface of the inner layer is abutted against the optical fiber; an outer layer, the inner surface of the outer layer is provided with a first concave-convex structure with a corrugate shaped, the first concave-convex structure being abutted against the optical fiber; wherein a active space is formed between the sensing band and the inner watchband and configured for the radial artery to beat; a calibration assembly configured to continuously calibrate blood pressure values; and a signal process assembly.Type: GrantFiled: May 8, 2019Date of Patent: March 21, 2023Assignee: HUIJIA HEALTH LIFE TECHNOLOGY CO., LTD.Inventor: Shuchen Yang
-
Patent number: 11610648Abstract: The method includes compressing numbers of reads data for targeted genes of a gene expression assay performed on a test sample. The targeted genes are organized into categories. Each category represents a functional context associated with the targeted genes in that category. The numbers of reads corresponding to targeted genes each category is compressed to form a compressed value for the category. The compressed value is compared to a baseline value for the category to determine an enrichment or a loss of a signature corresponding to the functional context of the category. The method may include analyzing information from multiple assays performed on the test sample, assigning a score value to each assay result and predicting a response to immune-oncology treatment based on the assigned scores.Type: GrantFiled: April 17, 2020Date of Patent: March 21, 2023Assignee: Life Technologies CorporationInventors: Fiona Hyland, Asha Kamat, Timothy Looney
-
Patent number: D983408Type: GrantFiled: June 14, 2022Date of Patent: April 11, 2023Assignee: Life Technologies CorporationInventors: David M. Liu, Kirk M. Hirano, Albert L. Carrillo, Alexander V. Dukhovny, Joseph A. Lazur, Peng Li, Joshua Mead
-
Patent number: D983813Type: GrantFiled: November 12, 2020Date of Patent: April 18, 2023Assignee: LIFE TECHNOLOGIES CORPORATIONInventors: Laurel Stone, Emily Zink, Sean Zimmerman, Nicholas Diliani
-
Patent number: D986432Type: GrantFiled: November 26, 2021Date of Patent: May 16, 2023Assignee: Shenzhen Jianyi Life Technology Co., Ltd.Inventor: Junming Zhang